Stockscreener 앱 받기
3.94
0.76%
-0.03
Karyopharm Therapeutics Inc 주식(KPTI)의 최신 뉴스
Layoff Tracker: Bicycle, Tune, Iovance, Precision Downsize to Conserve Cash - BioSpace
Earnings Outlook For Karyopharm Therapeutics - 富途牛牛
Visual trend scoring systems applied to Karyopharm Therapeutics Inc.Technical Reversal Setup with Risk Limits - Newser
Automated trading signals detected on Karyopharm Therapeutics Inc.Free Community Strategy With High Win Rate - Newser
Chart based exit strategy for Karyopharm Therapeutics Inc.Secure Entry Point Finder with Analysis - Newser
How moving averages guide Karyopharm Therapeutics Inc. tradingMarket Timing Strategy with Technical Filters - Newser
Karyopharm Therapeutics shares rise 1.78% after-hours following Bicycle Therapeutics' board expansion. - AInvest
Karyopharm Therapeutics Inc expected to post a loss of $4.10 a shareEarnings Preview - TradingView
Tick level data insight on Karyopharm Therapeutics Inc. volatilityTechnical Trade Plan with Entry Checklist - Newser
How Karyopharm Therapeutics Inc. stock reacts to Fed policy changesFree Weekly Potential Breakout Stock List - Newser
Karyopharm Therapeutics Inc (KPTI) Q2 2025 Earnings Report Preview: What To Expect - Yahoo Finance
What data driven models say about Karyopharm Therapeutics Inc.’s futureBuy Strategy Review With Performance Summary - Newser
Karyopharm to Report Second Quarter 2025 Financial Results on August 11, 2025 - Eastern Progress
Karyopharm Therapeutics Inc. stock prediction for this weekAI Swing Strategy Signal Forecasting System - Newser
Candlestick signals on Karyopharm Therapeutics Inc. stock todayHigh Reward Picks with Tight Risk Control - Newser
Is a relief rally coming for Karyopharm Therapeutics Inc. holdersFast Entry Strategy with Price Prediction - Newser
Karyopharm to Report Second Quarter 2025 Financial Results on Au - GuruFocus
Will Karyopharm Therapeutics Inc. stock split in the near futureStock Price Prediction Using AI Tools - Newser
Karyopharm Therapeutics Inc. Sees Spike in Bullish Option FlowPattern Alert With ROI Driven Strategy Shared - beatles.ru
Is Karyopharm Therapeutics Inc. a growth stock or a value stockTriple-digit profit margins - Jammu Links News
Why is Karyopharm Therapeutics Inc. stock attracting strong analyst attentionUnlock real-time trading signals for gains - Jammu Links News
What makes Karyopharm Therapeutics Inc. stock price move sharplyUnlock powerful portfolio management tools - Jammu Links News
How does Karyopharm Therapeutics Inc. compare to its industry peersAchieve impressive returns with smart timing - Jammu Links News
What is the risk reward ratio of investing in Karyopharm Therapeutics Inc. stockBuild a winning portfolio with smart picks - Jammu Links News
Will Karyopharm Therapeutics Inc. see short term momentumFree AI Screening for Swing Trade Picks - Newser
What institutional investors are buying Karyopharm Therapeutics Inc. stockFree Daily Trading Room Entry - Jammu Links News
Should I hold or sell Karyopharm Therapeutics Inc. stock in 2025Overwhelming financial success - Jammu Links News
When is Karyopharm Therapeutics Inc. stock expected to show significant growthCapitalize on fast-moving stock opportunities - Jammu Links News
Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Eastern Progress
Is Karyopharm Therapeutics Inc. stock overvalued or undervaluedRapid portfolio appreciation - Jammu Links News
Why Karyopharm Therapeutics Inc. stock attracts strong analyst attentionEntry Signal Momentum Tracker Review - beatles.ru
Karyopharm's Strategic Use of Inducement Grants to Attract Talent in a Competitive Biotech Landscape - AInvest
Karyopharm Therapeutics Awards 333 Restricted Stock Units to New Employee - AInvest
KARYOPHARM THERAPEUTICS Earnings Preview: Recent $KPTI Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Published on: 2025-07-30 09:02:26 - metal.it
Karyopharm Therapeutics (KPTI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance
What makes Karyopharm Therapeutics Inc. stock attractive to long term investorsGrowth Based Stock Signal Screener Updated - metal.it
Karyopharm Shares Slide After Financing Efforts Stall, Strategic Review Underway - MSN
How many analysts rate Karyopharm Therapeutics Inc. as a “Buy”Invest smarter with expert trading signals - Jammu Links News
How strong is Karyopharm Therapeutics Inc. company’s balance sheetPost Market Review For 2025 - Jammu Links News
Has Karyopharm Therapeutics Inc. found a price floorDaily Market Momentum and Pressure Analysis - Newser
0.24%
3.39%
자본화:
|
볼륨(24시간):